Aphios Pharma

Growth Stage

Inspired by Nature, Enabled by Science

Analytics

Raised to Date: Raised: $48,152

Aggregate Commitments $

Platform

Netcapital

Start Date

09/07/2018

Close Date

01/31/2019

Min. Goal

$10,000

Max. Goal

$1,070,000

Min. Investment

$99

Security Type

Equity - Common

Funding Type

RegCF

Price Per Share

$1.00

Pre-Money Valuation

$101,070,000

Rolling Commitments $

Status
Funded
Reporting Date

02/03/2019

Days Remaining
Funded
% of Min. Goal

482%

% of Max. Goal

5%

Likelihood of Max
Funded
Avg. Daily Raise

$330

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Location

Woburn, Massachusetts

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Aphios Pharma LLC is exploring how to best leverage, develop, and commercialize cannabis-based drugs for Central Nervous System (CNS) and other disorders. To accomplish this, Aphios Pharma “...utilizes supercritical fluid technologies to improve drug discovery, manufacturing, and formulation in a sustainable, environmentally-friendly manner.” They manufacture pharmaceutical-grade pure natural cannabinoids that both follow cGMP guidelines of the FDA and are in compliance with the Drug Enforcement Agency (DEA). So far, their work has led to endeavors that are likely to advance the science of cannabinoid-based medicines -- as well as make significant contributions to science and medicine.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Aphios Pharma 07/31/2022 Wefunder $71,000,000 $97,041 SAFE Funded RegCF
Aphios Pharma 01/31/2019 Netcapital $101,070,000 $48,152 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Aphios Pharma on Netcapital
$
Platform: Netcapital
Security Type: Equity - Common
Valuation: $101,070,000
Invest in a different round for this company? Use my investment date to determine which raise I invested in.

Follow company

Follow Aphios Pharma on Netcapital
View on Netcapital (Closed)
Bullish / Bearish
You're Bullish on Aphios Pharma on Netcapital

Thank you for your vote on Aphios Pharma on Netcapital

Bullish / Bearish
You're Bearish on Aphios Pharma on Netcapital

Thank you for your vote on Aphios Pharma on Netcapital